Elsevier

Virus Research

Volume 187, 17 July 2014, Pages 43-54
Virus Research

Hantaviruses and cardiopulmonary syndrome in South America

https://doi.org/10.1016/j.virusres.2014.01.015Get rights and content

Highlights

  • Hantavirus causing human disease in South America.

  • Rodents harboring hantavirus in South America.

  • The epidemiologic situation of hantavirus pulmonary syndrome in different countries of South America.

  • Aspects of the physiopathology and clinical presentation of hantavirus cardiopulmonary syndrome based on studies performed in South America.

Abstract

Hantavirus (Bunyaviridae) cardiopulmonary syndrome (HCPS) is an emerging health problem in South America due to urban growth and to the expansion of agriculture and cattle-raising areas into ecosystems containing most of the species of Sigmodontinae rodents that act as hantavirus reservoirs. About 4000 HCPS cases have been reported in South America up to 2013, associated with the following hantaviruses: Andes, Anajatuba, Araraquara (ARQV), Paranoá, Bermejo, Castelo dos Sonhos, Juquitiba, Araucária, Laguna Negra, Lechiguanas, Maripa, Oran, Rio Mamore and Tunari. The transmission of hantavirus to man occurs by contact with or through aerosols of excreta and secretions of infected rodents. Person-to-person transmission of hantavirus has also been reported in Argentina and Chile. HCPS courses with a capillary leaking syndrome produced by the hantavirus infecting lung endothelial cells and mostly with a severe inflammatory process associated with a cytokine storm. HCPS starts as a dengue-like acute febrile illness but after about 3 days progresses to respiratory failure and cardiogenic shock, leading to a high fatality rate that reaches 50% for patients infected with ARQV.

Introduction

Hantaviruses are important zoonotic pathogens related to rodents and other small mammals (shrews, moles and bats). When infecting man, hantaviruses can cause severe diseases with high case-fatality rates such as hemorrhagic fever with renal syndrome (HFRS) in Asia and Europe and hantavirus cardiopulmonary syndrome (HCPS) in the Americas. In both syndromes, capillary leakage of intravascular fluid into interstitial tissue leads to respiratory and renal failure and shock (Jonsson et al., 2010). However, a recent comparative analysis of HFRS and HCPS cases has revealed that syndromic names are mostly didactic and, in fact, patients from the Americas also have renal failure and patients from Europe and Asia have respiratory failure. Thus, the worldwide use of the term Hantavirus disease has been recently proposed (Clement et al., 2012; see also chapter X of this Special Issue).

The first case of an American hantavirus producing human disease, a cardiopulmonary syndrome caused by Sin Nombre virus (SNV), was reported in the United States Hughes et al. (1993). Dozens of hantavirus genotypes have been reported since then in the Americas associated with autochthonous rodent species of the subfamily Neotominae, Sigmodontinae and Arvicolinae (Jonsson et al., 2010). In South America, hantavirus reservoirs are Sigmodontinae American rodents that harbor the following viruses associated with human disease: Andes, Maciel, Oran, Lechiguanas, Laguna Negra and Bermejo in Argentina, Andes in Chile, Laguna Negra and Bermejo in Paraguay, Laguna Negra, Tunari and Bermejo in Bolivia, Maripa in French Guyana, Juquitiba, Andes and Lechiguanas in Uruguay, and Araraquara, Juquitiba/Araucária, Castelo dos Sonhos, Laguna Negra and Anajatuba in Brazil (Firth et al., 2012). A map of South America showing hantaviruses associated with disease and their rodent reservoirs is shown in Fig. 1.

Hantavirus disease is an emerging health problem in South America due to urban growth and the expansion of agriculture and cattle-raising areas into ecosystems containing most of the species of Sigmodontinae rodents that act as hantavirus reservoirs (Figueiredo et al., 2009b). The biodiversity of natural ecosystems of South America supports about 500 known species of Sigmodontinae (Mills, 2006, Mills et al., 2007).

The transmission of hantavirus to man occurs mostly by contact with or through aerosols of excreta and secretions of infected rodents (Butler and Peters, 1994), although human-to-human transmission of hantavirus has been reported in Argentina and Chile (Martinez et al., 2005, Padula et al., 1998, Wells et al., 1997).

Section snippets

The virus

Hantaviruses constitute a genus of the family Bunyaviridae that includes a large number of small mammal-borne viruses distributed worldwide. The hantavirus RNA genome, packed in particles 80 to 120 nm in size, comprises RNA of approximately 12,000 nucleotides divided into three negative-sense and single-stranded fragments (Schmaljohn and Dalrymple, 1983). These are named S (small), M (medium), and L (large) and encode the nucleoprotein (N), envelope glycoproteins (Gn and Gc), and the L protein

Epidemiology

In South America, the diversity and the distribution of hantavirus is highly complex (Padula et al., 2007). The eco-epidemiology of hantavirus depends on the microhabitat of its reservoir (Mills and Childs, 1998). Landscape composition, climate and seasonality, human agricultural activity and environmental degradation are important factors of hantavirus epidemiology. Based on phylogenetic studies of complete nucleotide sequences of the N gene, South American hantavirus strains or genetic

HCPS

About 4000 HCPS cases have been reported in the Americas since 1993, caused by more than 30 hantavirus strains or genetic lineages. Almost half of these HCPS cases occurred in Brazil where the disease is commonly seasonal. In the Cerrado regions of the Southeast and Central Plateau, HCPS is mostly reported from April through September during the dry winter season when agricultural activity is intense.

HCPS is a severe acute disease associated with a rapid onset of respiratory failure and

Pathogenesis

Hantavirus infects endothelial cells, altering capillary permeability and leading to acute pulmonary edema and HCPS Fig. 2 (Gavrilovskaya et al., 2012). Therefore, the hantavirus infection induces an inflammatory process with a strong immune response that may be the most important cause of disruption of the endothelial barrier. A cytokine study in 21 HCPS patients infected with ARQV showed that IL-6 may have an important role in the pathogenesis of HCPS, being associated with a fatal outcome (

Laboratory diagnosis

Considering that HCPS is a fast evolving disease commonly confused with other severe diseases such as bacterial sepsis, it is important to collect early clinical samples for testing with rapid diagnostic methods. Sensitive and rapid diagnostic tests have been developed based on the detection of anti-hantavirus IgM and IgG antibodies and on the viral genome (Machado et al., 2009).

IgM and IgG antibodies to the hantavirus structural proteins (N, Gn and Gc) are detectable in practically all HCPS

Management

Ribavirin has been successfully used for the treatment of HFRS in Chinese patients. When initiated in the first week of illness, ribavirin reduces oliguria and renal insufficiency. However, the use of ribavirin in HCPS patients has shown inconclusive results and had no apparent clinical benefit (Chapman et al., 2002, Mertz et al., 2006).

The administration of human neutralizing antibodies to HCPS patients in the viremic phase might be effective as treatment. Studies of passive transfer of sera

Prophylaxis

An inactivated virus vaccine against hantavirus is extensively used in China and Korea. Approximately 2 million doses of HFRS vaccines derived from inactivated rodent brain or cell culture are given annually in China and were able to reduce the number of HFRS cases to less than a half (Zhang et al., 2010) (Kruger et al., 2011). There is no vaccine available for American hantavirus. The development of a vaccine for American hantavirus is difficult due to the lack of an animal model of hantavirus

Acknowledgments

We acknowledge the Brazilian National Research Council (CNPq) for Grant 302509/87-9/BM/FV and the São Paulo State Research Council (FAPESP) for Grant 12/24150-9. We also acknowledge Mrs. Elettra Greene for review of the manuscript.

References (127)

  • S.M. Raboni et al.

    Evidence of circulation of Laguna Negra-like hantavirus in the central west of Brazil: case report

    J. Clin. Virol.

    (2009)
  • J. Antonen et al.

    A severe case of Puumala hantavirus infection successfully treated with bradykinin receptor antagonist icatibant

    Scand. J. Infect. Dis.

    (2013)
  • S.J. Badra et al.

    A retrospective serologic survey of hantavirus infections in the county of Cassia dos Coqueiros, State of Sao Paulo, Brazil

    Rev. Soc. Bras. Med. Trop.

    (2012)
  • M. Baro et al.

    Hantavirus in Chile: review and cases analysis since 1975

    Rev. Med. Chil.

    (1999)
  • A.A. Borges et al.

    Polymorphisms in human leukocyte antigens, human platelet antigens, and cytokine genes in hantavirus cardiopulmonary syndrome patients from Ribeirão Preto, Brazil

    J. Med. Virol.

    (2013)
  • A.A. Borges et al.

    Association of −308G/A polymorphism in the tumor necrosis factor-alpha gene promoter with susceptibility to development of hantavirus cardiopulmonary syndrome in the Ribeirao Preto region, Brazil

    Arch. Virol.

    (2010)
  • M. Boroja et al.

    Radiographic findings in 20 patients with hantavirus pulmonary syndrome correlated with clinical outcome

    AJR Am. J. Roentgenol.

    (2002)
  • J.C. Butler et al.

    Hantaviruses and hantavirus pulmonary syndrome

    Clin. Infect. Dis.

    (1994)
  • G.M. Campos et al.

    Pulmonary and cardiovascular syndrome due to hantavirus: clinical aspects of an emerging disease in southeastern Brazil

    Rev. Soc. Bras. Med. Trop.

    (2009)
  • G.M. Campos et al.

    Serological survey of hantavirus in Jardinopolis County, Brazil

    J. Med. Virol.

    (2003)
  • D.S. Carroll et al.

    Hantavirus pulmonary syndrome in Central Bolivia: relationships between reservoir hosts, habitats, and viral genotypes

    Am. J. Trop. Med. Hyg.

    (2005)
  • M. Casapia et al.

    Hantavirus pulmonary syndrome (Rio Mamore virus) in the Peruvian Amazon region

    Revista peruana de medicina experimental y salud publica

    (2012)
  • C. Castillo et al.

    Prevalence of antibodies to hantavirus among family and health care worker contacts of persons with hantavirus cardiopulmonary syndrome: lack of evidence for nosocomial transmission of Andes virus to health care workers in Chile

    Am. J. Trop. Med. Hyg.

    (2004)
  • Ore R.M. Castillo et al.

    Serologic evidence for human hantavirus infection in Peru

    Vector Borne Zoonotic Dis.

    (2012)
  • L.E. Chapman et al.

    Discriminators between hantavirus-infected and -uninfected persons enrolled in a trial of intravenous ribavirin for presumptive hantavirus pulmonary syndrome

    Clin. Infect. Dis.

    (2002)
  • Y.K. Chu et al.

    The complex ecology of hantavirus in Paraguay

    Am. J. Trop. Med. Hyg.

    (2003)
  • J. Clement et al.

    A unifying hypothesis and a single name for a complex globally emerging infection: hantavirus disease

    Eur. J. Clin. Microbiol. Infect. Dis.

    (2012)
  • C.D. Cruz et al.

    Novel strain of Andes virus associated with fatal human infection, central Bolivia

    Emerg. Infect. Dis.

    (2012)
  • D.M. Custer et al.

    Active and passive vaccination against hantavirus pulmonary syndrome with Andes virus M genome segment-based DNA vaccine

    J. Virol.

    (2003)
  • M.V. da Silva et al.

    Hantavirus pulmonary syndrome: report of the first three cases in Sao Paulo, Brazil

    Rev. Inst. Med. Trop. Sao Paulo

    (1997)
  • R.L. de Sousa et al.

    Natural host relationships and genetic diversity of rodent-associated hantaviruses in southeastern Brazil

    Intervirology

    (2008)
  • A. Delfraro et al.

    Yellow pigmy rice rat (Oligoryzomys flavescens) and hantavirus pulmonary syndrome in Uruguay

    Emerg. Infect. Dis.

    (2003)
  • A. Delfraro et al.

    Juquitiba-like hantavirus from 2 nonrelated rodent species, Uruguay

    Emerg. Infect. Dis.

    (2008)
  • G.S. dos Santos Junior et al.

    Hantavirus epidemiological studies in Brazilian Sigmodontinae rodents

  • J.S. Duchin et al.

    Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. The Hantavirus Study Group

    N. Engl. J. Med.

    (1994)
  • J.F. Ferrer et al.

    Hantavirus infection in people inhabiting a highly endemic region of the Gran Chaco territory, Paraguay: association with Trypanosoma cruzi infection, epidemiological features and haematological characteristics

    Ann. Trop. Med. Parasitol.

    (2003)
  • J.F. Ferrer et al.

    High prevalence of hantavirus infection in Indian communities of the Paraguayan and Argentinean Gran Chaco

    Am. J. Trop. Med. Hyg.

    (1998)
  • M. Ferres et al.

    Prospective evaluation of household contacts of persons with hantavirus cardiopulmonary syndrome in Chile

    J. Infect. Dis.

    (2007)
  • M. Ferres et al.

    Presence of Andes virus genome in gingival crevicular fluid during acute hantavirus infection

  • G.G. Figueiredo et al.

    Diagnosis of hantavirus infection in humans and rodents in Ribeirao Preto, State of Sao Paulo, Brazil

    Rev. Soc. Bras. Med. Trop.

    (2010)
  • L.T. Figueiredo et al.

    Evaluation of an enzyme-linked immunosorbent assay based on Araraquara virus recombinant nucleocapsid protein

    Am. J. Trop. Med. Hyg.

    (2009)
  • L.T. Figueiredo et al.

    Expression of a hantavirus N protein and its efficacy as antigen in immune assays

    Braz. J. Med. Biol. Res.

    (2008)
  • L.T. Figueiredo et al.

    Hantavirus pulmonary syndrome, central plateau, southeastern, and southern Brazil

    Emerg. Infect. Dis.

    (2009)
  • C. Firth et al.

    Diversity and distribution of hantaviruses in South America

    J. Virol.

    (2012)
  • I. Gavrilovskaya et al.

    The role of the endothelium in HPS pathogenesis and potential therapeutic approaches

    Adv. Virol.

    (2012)
  • J.B. Gimaque et al.

    Serological evidence of hantavirus infection in rural and urban regions in the state of Amazonas, Brazil

    Mem. Inst. Oswaldo Cruz

    (2012)
  • P. Godoy et al.

    Andes virus antigens are shed in urine of patients with acute hantavirus cardiopulmonary syndrome

    J. Virol.

    (2009)
  • C. Guzman et al.

    Prevalence of antibody to hantaviruses in humans and rodents in the Caribbean region of Colombia determined using Araraquara and Maciel virus antigens

    Mem. Inst. Oswaldo Cruz

    (2013)
  • J.M. Hughes et al.

    Hantavirus pulmonary syndrome: an emerging infectious disease

    Science

    (1993)
  • K.M. Jaaskelainen et al.

    Tula and Puumala hantavirus NSs ORFs are functional and the products inhibit activation of the interferon-beta promoter

    J. Med.Virol.

    (2007)
  • Cited by (85)

    • Hantavirus Disease: A Global Update over the Last Decade

      2024, Rising Contagious Diseases: Basics, Management, and Treatments
    View all citing articles on Scopus
    View full text